KODIAK AI INC (KDK) Fundamental Analysis & Valuation

NASDAQ:KDK • US5000811043

Current stock price

8.0399 USD
+0.64 (+8.65%)
Last:

This KDK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. KDK Profitability Analysis

1.1 Basic Checks

  • In the past year KDK has reported negative net income.
  • KDK had a negative operating cash flow in the past year.
  • In the past 5 years KDK always reported negative net income.
  • In the past 5 years KDK always reported negative operating cash flow.
KDK Yearly Net Income VS EBIT VS OCF VS FCFKDK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -100M -200M -300M -400M -500M

1.2 Ratios

  • With a Return On Assets value of -365.44%, KDK is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -365.44%
ROE N/A
ROIC N/A
ROA(3y)-228.55%
ROA(5y)-137.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDK Yearly ROA, ROE, ROICKDK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KDK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDK Yearly Profit, Operating, Gross MarginsKDK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 -5K -10K -15K

4

2. KDK Health Analysis

2.1 Basic Checks

  • KDK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KDK has less shares outstanding
  • Compared to 1 year ago, KDK has an improved debt to assets ratio.
KDK Yearly Shares OutstandingKDK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
KDK Yearly Total Debt VS Total AssetsKDK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • KDK has an Altman-Z score of -5.42. This is a bad value and indicates that KDK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -5.42, KDK is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.42
ROIC/WACCN/A
WACC9.15%
KDK Yearly LT Debt VS Equity VS FCFKDK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 -50M -100M

2.3 Liquidity

  • KDK has a Current Ratio of 4.73. This indicates that KDK is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of KDK (4.73) is better than 90.48% of its industry peers.
  • KDK has a Quick Ratio of 4.73. This indicates that KDK is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 4.73, KDK belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.73
Quick Ratio 4.73
KDK Yearly Current Assets VS Current LiabilitesKDK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

3

3. KDK Growth Analysis

3.1 Past

  • The earnings per share for KDK have decreased strongly by -1432.14% in the last year.
  • Looking at the last year, KDK shows a very negative growth in Revenue. The Revenue has decreased by -72.30% in the last year.
EPS 1Y (TTM)-1432.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-429.04%
Revenue 1Y (TTM)-72.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-92.32%

3.2 Future

  • KDK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.41% yearly.
  • Based on estimates for the next years, KDK will show a very strong growth in Revenue. The Revenue will grow by 295.52% on average per year.
EPS Next Y77.45%
EPS Next 2Y34.6%
EPS Next 3Y23.41%
EPS Next 5YN/A
Revenue Next Year238.41%
Revenue Next 2Y334.98%
Revenue Next 3Y295.52%
Revenue Next 5YN/A

3.3 Evolution

KDK Yearly Revenue VS EstimatesKDK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
KDK Yearly EPS VS EstimatesKDK Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 -1 -2 -3

1

4. KDK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KDK. In the last year negative earnings were reported.
  • Also next year KDK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDK Price Earnings VS Forward Price EarningsKDK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDK Per share dataKDK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • KDK's earnings are expected to grow with 23.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.6%
EPS Next 3Y23.41%

0

5. KDK Dividend Analysis

5.1 Amount

  • KDK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

KDK Fundamentals: All Metrics, Ratios and Statistics

KODIAK AI INC

NASDAQ:KDK (4/14/2026, 10:25:58 AM)

8.0399

+0.64 (+8.65%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners35.58%
Inst Owner Change0%
Ins Owners17.45%
Ins Owner Change0.02%
Market Cap1.47B
Revenue(TTM)3.80M
Net Income(TTM)-582.53M
Analysts82.22
Price Target16.01 (99.13%)
Short Float %4.49%
Short Ratio10.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-233.12%
Min EPS beat(2)-345.28%
Max EPS beat(2)-120.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-47.43%
Min Revenue beat(2)-99.84%
Max Revenue beat(2)4.99%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.26%
PT rev (3m)-1.26%
EPS NQ rev (1m)-3.97%
EPS NQ rev (3m)-3.97%
EPS NY rev (1m)-5.75%
EPS NY rev (3m)-5.64%
Revenue NQ rev (1m)25.34%
Revenue NQ rev (3m)25.34%
Revenue NY rev (1m)-4.14%
Revenue NY rev (3m)-99.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 386.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.2
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0.02
BVpS-0.33
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -365.44%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-228.55%
ROA(5y)-137.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 678.14%
Cap/Sales 580.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.73
Quick Ratio 4.73
Altman-Z -5.42
F-Score3
WACC9.15%
ROIC/WACCN/A
Cap/Depr(3y)275.59%
Cap/Depr(5y)N/A
Cap/Sales(3y)206.92%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1432.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-429.04%
EPS Next Y77.45%
EPS Next 2Y34.6%
EPS Next 3Y23.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-72.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-92.32%
Revenue Next Year238.41%
Revenue Next 2Y334.98%
Revenue Next 3Y295.52%
Revenue Next 5YN/A
EBIT growth 1Y-974.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.5%
EBIT Next 3Y20.51%
EBIT Next 5YN/A
FCF growth 1Y-115.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.32%
OCF growth 3YN/A
OCF growth 5YN/A

KODIAK AI INC / KDK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KODIAK AI INC?

ChartMill assigns a fundamental rating of 2 / 10 to KDK.


Can you provide the valuation status for KODIAK AI INC?

ChartMill assigns a valuation rating of 1 / 10 to KODIAK AI INC (KDK). This can be considered as Overvalued.


How profitable is KODIAK AI INC (KDK) stock?

KODIAK AI INC (KDK) has a profitability rating of 0 / 10.


What is the earnings growth outlook for KODIAK AI INC?

The Earnings per Share (EPS) of KODIAK AI INC (KDK) is expected to grow by 77.45% in the next year.